Evidence Hub

Comparative Augmentative Efficacy of Second-Generation Antipsychotics in Adult Treatment-Resistant Depression: A Systematic Review

Rashed Khalid, Gihad Elbashir, Ahmed E. Hassan, Mayada Abdulbagi

Cureus, 2026

5,300 participants · 1 citation

Abstract

Treatment-resistant depression (TRD) affects a substantial proportion of patients with major depressive disorder and remains a major therapeutic challenge. Augmentation with second-generation antipsychotics (SGAs) is commonly used; however, comparative evidence regarding their efficacy and safety remains limited. This systematic review aimed to evaluate the augmentative efficacy and tolerability of SGAs in adults with TRD. A systematic search of PubMed/MEDLINE, Embase, Web of Science, Scopus, and the Cochrane Library was conducted for randomized controlled trials published between 2016 and 2025. Eligible studies included adults with TRD receiving SGA augmentation. Two reviewers independently screened studies, extracted data, and assessed risk of bias using the Cochrane RoB 2 tool. Due to clinical heterogeneity across interventions and outcomes, findings were synthesized narratively. Eleven randomized controlled trials including 5,300 participants were analyzed, evaluating brexpiprazole, cariprazine, aripiprazole, and quetiapine XR. Most studies reported greater reductions in depressive symptoms compared with placebo, commonly measured by changes in the Montgomery-Åsberg Depression Rating Scale. Brexpiprazole and the aripiprazole-sertraline combination showed the most consistent improvements, with brexpiprazole augmentation yielding remission rates ranging from 22 to 31% and cariprazine augmentation showing rates of 22-32% across flexible-dose trials. Several agents…

How strong is the evidence?

Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 5,300 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free